
We offer adequate clinical diagnosis with the support of a multidisciplinary team and a centre for clinical trials. Research in the Laboratory of Neuroscience mainly focuses on genetics of ALS, ALS disease mechanisms using in vitro cell models, iPSCs as a bioassay of clinical relevance, and biomarker identification. We have made a big effort to develop eye tracking and BCI technologies for the definition of neuropsychological changes in people with ALS. The Milan ALS Centre has been audited by FDA in 1997 for a clinical trial.